Urolithin A (CAS No. 1143-70-0) is supplied by Jinan Shenghe Chemical Co., Ltd. with a typical purity of 按批次COA提供(不公开发布). Main applications include Organic Chemicals;Pharmaceutical Raw Materials. Bulk quantities are available with COA; purity and packaging are subject to batch COA and order confirmation.
Organic Chemicals;Pharmaceutical Raw Materials
COA provided with every batch; MSDS and technical documents available on request. Email us with product name and CAS number for a quote within one business day.
The CAS number of Urolithin A is 1143-70-0.
Typical purity is 按批次COA提供(不公开发布), supplied in 按订单/批次确认(不公开发布), with COA provided.
Main applications include Organic Chemicals;Pharmaceutical Raw Materials.
Email info@591daili.com or reach us on WhatsApp with the product name, CAS number and required quantity; quotes within one business day. Supplier: Jinan Shenghe Chemical Co., Ltd..
尿石素A · CAS 1143-70-0 · C13H8O4. UNII ILJ8NEF6DT.
| CAS 号 | 1143-70-0 |
|---|---|
| PubChem CID | 5488186 |
| 分子式 | C13H8O4 |
| IUPAC 名称 | 3,8-dihydroxybenzo[c]chromen-6-one |
| UNII(FDA) | ILJ8NEF6DT |
| Molecular Weight | 228.20 |
|---|---|
| XLogP3 | 2.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 0 |
| Exact Mass | 228.04225873 |
| Monoisotopic Mass | 228.04225873 |
| Topological Polar Surface Area | 66.8 |
| Heavy Atom Count | 17 |
| Formal Charge | 0 |
| 法规与食品接触 | Scientific procedures FDA has no questions (in PDF) Amazentis SA |
|---|
| 已通报的危害声明 | H315 (100%), H319 (100%) |
|---|
urolithin A; 1143-70-0; 3,8-dihydroxy-6H-benzo[c]chromen-6-one; 3,8-Dihydroxyurolithin; 6H-Dibenzo[b,d]pyran-6-one, 3,8-dihydroxy-; 3,8-dihydroxybenzo[c]chromen-6-one; 3,8-Hydroxydibenzo-alpha-pyrone; ILJ8NEF6DT; Mitopure; DTXSID40150694; 6H-Dibenzo(b,d)pyran-6-one, 3,8-dihydroxy-; 3,8-DIHYDROXYBENZO(C)CHROMEN-6-ONE; 3,8-dihydroxy-6H-benzo(c)chromen-6-one; RefChem:193319; DTXCID3073185; 881-478-5
CAS 号 1143-70-0;分子式 C13H8O4;分子量 — g/mol。
urolithin A, 1143-70-0, 3,8-dihydroxy-6H-benzo[c]chromen-6-one, 3,8-Dihydroxyurolithin, 6H-Dibenzo[b,d]pyran-6-one, 3,8-dihydroxy-, 3,8-dihydroxybenzo[c]chromen-6-one.
已记录的法规记录:科学程序; FDA 没有提出任何问题(PDF 格式); Amazentis SA。
已通报的危害声明:H315, H319。
本页事实取自 PubChem(美国国家医学图书馆)与 Wikidata。批号相关的数据——含量、水分、粒度、包装、保质期——随批次 COA 出具,不在本页公布。
Supplier: Jinan Shenghe Chemical Co., Ltd. · Reply within one business day.